We analyze a nonlinear q-voter mannequin with stochastic noise, interpreted within the social context as independence, on a duplex community. The dimensions of the foyer q (i.e., the stress group) is an important parameter that adjustments the conduct of the system. The q-voter mannequin has been utilized on multiplex networks, and it has been proven that the character of the part transition is dependent upon the variety of ranges within the multiplex community in addition to on the worth of q.
The first purpose of this research is to look at part transition character within the case when on every stage of the community the foyer measurement is totally different, leading to two parameters q1 and q2. In a system of a duplex clique (i.e., two totally overlapped full graphs) we discover proof of successive part transitions when a steady part transition is adopted by a discontinuous one or two consecutive discontinuous part transitions seem, relying on the parameter. When analyzing this technique, we even encounter mixed-order (or hybrid) part transition. The statement of successive part transitions is a brand new amount in binary state opinion formation fashions and we present that our analytical issues are totally supported by Monte-Carlo simulations.
Extra notes on the publication of the Narrative, Zoology and Notes from a Journal of Analysis into the Pure Historical past of the Voyage of H.M.S. Samarang and its penalties for the nomenclature of decapod crustaceans and different taxa
Captain Edward Belcher was instructed by the Lords of the Admiralty to conduct a Surveying Expedition of the assorted coasts and islands within the Jap Seas utilizing H.M.S. Samarang. Throughout this voyage from 1843-1846, Assistant-Surgeon Arthur Adams, made a big contribution to the gathering of pure historical past specimens, and along with fellow officers J. Richards and W. Browne, he ready quite a few drawings utilized by Belcher for instance the Narrative of the voyage.
Later, Adams collaborated with Adam White (an Assistant within the Zoological Department of the British Museum) to explain the Samarang Crustacea, revealed collectively with Lovell Reeve on the Samarang Mollusca, edited the Zoology of the voyage of H.M.S. Samarang and was the creator of Notes from a Journal of the Pure Historical past which was revealed within the Narrative of the voyage by Belcher. In his Pure Historical past, Adams offered detailed accounts on a number of the crustaceans collected with formal descriptions of species new to science thereby making these names accessible. The historical past, nomenclature and validity of the crustacean species cited on this work is mentioned and a listing of the accessible names is tabulated.
The New Biology as an Instance of Newspeak: The Case of Polish Zoology, 1948-1956.
The “New Biology” that arose within the Jap Block throughout Stalinist occasions was primarily based on the thought of the heritability of acquired traits. In rejecting the paradigm of Mendelian chromosome genetics in addition to science-based farming, the New Biology led to a deterioration of scientific life and the free trade of concepts. In imposing Lysenko’s concepts onto zoology, the New Biology adopted the totalitarian language of Newspeak, which dominated public discourse in communist international locations.
Newspeak had a number of defining parts: a restricted dictionary, sturdy valuations, binary oppositions, the magical operate of language, militarization, and ritualization of language. On this research, the idea of Newspeak is used to investigate major sources (publications, speeches, and convention discussions) in Polish zoology within the interval between 1948 and 1956. As soon as the observe of Newspeak started to wane, so did the New Biology that had been based on this particular ritualistic language.
Ludwig Heinrich Bojanus (1776-1827) on Gall’s craniognomic system, zoology, and comparative anatomy.
Most of what was recognized about Franz Joseph Gall’s (1758-1828) organology or Schädellehre previous to the 1820s got here from secondary sources, together with letters from correspondents, promotional supplies, transient newspaper articles about his lecture-demonstrations, and editions and translations of some lengthier works of various high quality in German. Doctor Ludwig Heinrich Bojanus (1776-1827) practiced in Vienna’s Basic Hospital in 1797-1798; attended a few of Gall’s public lectures; and, in 1801-1802, grew to become one of many first physicians to supply detailed reviews on Gall’s rising organology in French and English, respectively.
Though Bojanus thought of the human thoughts to be indivisible and didn’t fully agree with Gall’s assumption that the mind consists of numerous impartial organs chargeable for varied schools, he offered helpful info and considerate commentary on Gall’s views. Moreover, he defended Gall towards the cost that his type of pondering would result in materialism and cautiously predicted that the brand new system can be fruitful for growing and stimulating essential new analysis in regards to the mind and thoughts.
Doxorubicin |
|||
A3966-S | ApexBio | Evaluation Sample | EUR 22 |
Description: Topo II inhibitor,immunosuppresive antineoplastic antibiotic |
Doxorubicin |
|||
ADC-P-013 | Creative Biolabs | unit | Ask for price |
Doxorubicin |
|||
T1456-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
T1456-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin |
Doxorubicin |
|||
HY-15142A | MedChemExpress | 100mg | EUR 258 |
Doxorubicin |
|||
MBS3840348-100mg | MyBiosource | 100mg | EUR 165 |
Doxorubicin |
|||
MBS3840348-500mg | MyBiosource | 500mg | EUR 345 |
Doxorubicin |
|||
MBS3840348-50mg | MyBiosource | 50mg | EUR 135 |
Doxorubicin |
|||
MBS3840348-5x500mg | MyBiosource | 5x500mg | EUR 1550 |
Doxorubicin HCl |
|||
20-abx184016 | Abbexa |
|
|
Doxorubicin [BSA] |
|||
DAG-WT1084B | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin [OVA] |
|||
DAG-WT1084O | Creative Diagnostics | 1 mg | EUR 520 |
Description: Synthetic |
Doxorubicin HCl |
|||
abx076623-25ml | Abbexa | 25 ml | EUR 187.5 |
Doxorubicin HCl |
|||
abx076623-5ml | Abbexa | 5 ml | EUR 118.75 |
Doxorubicin 10mM |
|||
TG4120 | TopoGen | 0.25ml | EUR 187.2 |
Doxorubicin-HCl |
|||
MBS406798-1mg | MyBiosource | 1mg | EUR 1205 |
Doxorubicin-HCl |
|||
MBS406798-5x1mg | MyBiosource | 5x1mg | EUR 5385 |
Doxorubicin-SMCC |
|||
406622 | MedKoo Biosciences | 1.0mg | EUR 90 |
Doxorubicin-MVCP |
|||
T31567-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-MVCP |
|||
T31567-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-MVCP |
Doxorubicin-SMCC |
|||
T15161-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-SMCC |
|||
T15161-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin-SMCC |
Doxorubicin-MVCP |
|||
MBS5781169-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Doxorubicin-SMCC |
|||
HY-116063 | MedChemExpress | 10 mg | EUR 919.93 |
Description: Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin[1]. |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-10mg | MyBiosource | 10mg | EUR 680 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-1mg | MyBiosource | 1(mg | EUR 320 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-25mg | MyBiosource | 25mg | EUR 1495 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-5mg | MyBiosource | 5mg | EUR 435 |
Doxorubicinone (Adriamycinone, Doxorubicin aglycone) |
|||
MBS6049057-5x25mg | MyBiosource | 5x25mg | EUR 6570 |
Doxorubicin-13C,d3 (TFA) |
|||
HY-15142AS1 | MedChemExpress | 1mg | Ask for price |
Description: Doxorubicin-13C,d3 (TFA) is the deuterium and 13C labeled Doxorubicin. Doxorubicin (Hydroxydaunorubicin), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stoppin |
Adriamycin (Doxorubicin) |
|||
E1KS1208 | EnoGene | 10mg | EUR 276 |
Adriamycin (Doxorubicin) |
|||
MBS8579811-10mg | MyBiosource | 10mg | EUR 345 |
Adriamycin (Doxorubicin) |
|||
MBS8579811-5x10mg | MyBiosource | 5x10mg | EUR 1410 |
Doxorubicin (Adriamycin) |
|||
MBS576816-100mg | MyBiosource | 100mg | EUR 150 |
Doxorubicin (Adriamycin) |
|||
MBS576816-200mg | MyBiosource | 200mg | EUR 180 |
Doxorubicin (Adriamycin) |
|||
MBS576816-25mg | MyBiosource | 25mg | EUR 135 |
Doxorubicin (Adriamycin) |
|||
MBS576816-500mg | MyBiosource | 500mg | EUR 245 |
Doxorubicin (Adriamycin) |
|||
MBS576816-50mg | MyBiosource | 50mg | EUR 145 |
Zoptarelin doxorubicin |
|||
HY-16532 | MedChemExpress | Get quote | Ask for price |
Description: Zoptarelin doxorubicin (AEZS-108; AN-152) is a hybrid anticancer agent, containing Zoptarelin and Doxorubicin. Zoptarelin doxorubicin has been used to research targeting tumors expressing LHRH receptors. Zoptarelin doxorubicin abolishes tumor progression and induces remarkable apoptosis in vitro[1]. |
Doxorubicin HCl, 100mg |
|||
R2531 | ACTGene | 100mg | EUR 1080.79 |
Doxorubicin HCl, 100mg |
|||
R2531-100mg | ACTGene | each | EUR 1560 |
Doxorubicin HCl, 10mg |
|||
R2531-10mg | ACTGene | each | EUR 236.4 |
Doxorubicin Free Base |
|||
100960 | MedKoo Biosciences | 10.0mg | EUR 150 |
Doxorubicin Hydrochloride |
|||
20-abx076623 | Abbexa |
|
|
Doxorubicin hydrochloride |
|||
100280 | MedKoo Biosciences | 100.0mg | EUR 150 |
Doxorubicin Hydrochloride |
|||
40410004-1 | Glycomatrix | 10 mg | EUR 136.34 |
Doxorubicin Hydrochloride |
|||
40410004-2 | Glycomatrix | 25 mg | EUR 273.17 |
Doxorubicin Hydrochloride |
|||
D558000 | Toronto Research Chemicals | 100mg | EUR 136 |
Description: 25316-40-9 |
Doxorubicin hydrochloride |
|||
ADC-P-014 | Creative Biolabs | unit | Ask for price |
Hydroxyacetyl Doxorubicin |
|||
H415946 | Toronto Research Chemicals | 25mg | EUR 15000 |
Doxorubicin (hydrochloride) |
|||
HY-15142 | MedChemExpress | 100mg | EUR 176.4 |
Doxorubicin hydrochloride |
|||
GA4969-100MG | Glentham Life Sciences | 100 mg | EUR 217.2 |
Doxorubicin hydrochloride |
|||
GA4969-10MG | Glentham Life Sciences | 10 mg | EUR 93.6 |
Doxorubicin hydrochloride |
|||
GA4969-25MG | Glentham Life Sciences | 25 mg | EUR 117.6 |
Doxorubicin hydrochloride |
|||
GA4969-50MG | Glentham Life Sciences | 50 mg | EUR 151.2 |
Doxorubicin Hydrochloride |
|||
SIH-390-10MG | Stressmarq | 10 mg | EUR 129 |
Description: Apoptosis Inducer |
Doxorubicin Hydrochloride |
|||
SIH-390-50MG | Stressmarq | 50 mg | EUR 465 |
Description: Apoptosis Inducer |
Doxorubicin hydrochloride |
|||
T1020-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
T1020-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Doxorubicin hydrochloride |
Doxorubicin hydrochloride |
|||
TNC00267 | ChemNorm | 20mg | Ask for price |
Doxorubicin Hydrochloride |
|||
MBS651404-25mg | MyBiosource | 25mg | EUR 460 |
Doxorubicin Hydrochloride |
|||
MBS651404-5x25mg | MyBiosource | 5x25mg | EUR 1925 |
Doxorubicin Hydrochloride |
|||
MBS808094-10mg | MyBiosource | 10mg | EUR 250 |
Doxorubicin Hydrochloride |
|||
MBS808094-50mg | MyBiosource | 50mg | EUR 570 |
Doxorubicin Hydrochloride |
|||
MBS808094-5x10mg | MyBiosource | 5x10mg | EUR 880 |
Doxorubicin Hydrochloride |
|||
MBS808094-5x50mg | MyBiosource | 5x50mg | EUR 2300 |
Doxorubicin hydrochloride |
|||
MBS3603751-100mg | MyBiosource | 100mg | EUR 210 |
Doxorubicin hydrochloride |
|||
MBS3603751-200mg | MyBiosource | 200mg | EUR 245 |
Doxorubicin hydrochloride |
|||
MBS3603751-25mg | MyBiosource | 25mg | EUR 195 |
Doxorubicin hydrochloride |
|||
MBS3603751-500mg | MyBiosource | 500mg | EUR 315 |
Doxorubicin hydrochloride |
|||
MBS3603751-5x500mg | MyBiosource | 5x500mg | EUR 1075 |
Doxorubicin (Adriamycin) HCl |
|||
A1832-10 | ApexBio | 10 mg | EUR 36 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-100 | ApexBio | 100 mg | EUR 128 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-25 | ApexBio | 25 mg | EUR 52 |
Description: Antitumour antibiotic,inhibits TOPO II. |
Doxorubicin (Adriamycin) HCl |
|||
A1832-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 44 |
Description: Antitumour antibiotic,inhibits TOPO II. |
4'O-Benzyl Doxorubicin |
|||
B788120 | Toronto Research Chemicals | 100mg | EUR 1200 |
Description: 677017-23-1 |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1g | TargetMol Chemicals | 1g | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
N-(Iodoacetamido)-Doxorubicin |
|||
T18418-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin |
Doxorubicin hydrochloride, 98% |
|||
GP9056 | Glentham Life Sciences | 25mg | EUR 128.36 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-100 | Glentham Life Sciences | 100 | EUR 140.2 |
Doxorubicin hydrochloride, 98% |
|||
GP9056-25 | Glentham Life Sciences | 25 | EUR 56.1 |
N-(Iodoacetamido)-Doxorubicin |
|||
HY-141158 | MedChemExpress | Get quote | Ask for price |
Description: N-(Iodoacetamido)-Doxorubicin is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. |
Doxorubicin hydrochloride USP |
|||
D005-10MG | TOKU-E | 10 mg | EUR 117.34 |
Description: C27H29NO11•HCl |
Doxorubicin hydrochloride USP |
|||
D005-25MG | TOKU-E | 25 mg | EUR 234.67 |
Description: C27H29NO11•HCl |
7-Deoxy Doxorubicin Aglycone |
|||
MBS6103909-1mg | MyBiosource | 1(mg | EUR 610 |
7-Deoxy Doxorubicin Aglycone |
|||
MBS6103909-5x1mg | MyBiosource | 5x1mg | EUR 2600 |
10 mM Doxorubicin hydrochloride |
|||
DOX10 | ProFoldin | 100 ul | EUR 92 |
7-Deoxy Doxorubicin Aglycone (> 75%) |
|||
D232910 | Toronto Research Chemicals | 10mg | EUR 299 |
Description: 38554-25-5 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969 | Glentham Life Sciences | 10mg | EUR 137.69 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-10 | Glentham Life Sciences | 10 | EUR 47.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-100 | Glentham Life Sciences | 100 | EUR 150.4 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-25 | Glentham Life Sciences | 25 | EUR 67.2 |
Doxorubicin hydrochloride, USP grade |
|||
GA4969-50 | Glentham Life Sciences | 50 | EUR 95 |
PEGylated Liposomal Doxorubicin- 2 mg |
|||
PHPC002DX | ProFoldin | 2 mg | EUR 140.62 |
Description: This product includes 1 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
PEGylated Liposomal Doxorubicin- 20 mg |
|||
PHPC020DX | ProFoldin | 20 mg | EUR 358.62 |
Description: This product includes 10 ml of liposomal doxorubicin at concentrations of 2 mg/ml doxorubicin and 16 mg/ml of lipids. |
N-(9-Fluorenylmethoxycarbonyl) Doxorubicin |
|||
MBS651297-10mg | MyBiosource | 10mg | EUR 505 |
N-(9-Fluorenylmethoxycarbonyl) Doxorubicin |
|||
MBS651297-5x10mg | MyBiosource | 5x10mg | EUR 2125 |
Doxorubicin-hydrazone-caproyl-maleimide |
|||
D558040 | Toronto Research Chemicals | 100mg | EUR 1800 |
Description: 151038-96-9 |
Doxorubicin, Hydrochloride Salt [CAS# 25316-40-9] |
|||
D-4000 | LC LABORATORIES | 25 mg | EUR 40 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
IHUHELADTLW500UG | Innovative research | each | EUR 327 |
Description: Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
MBS8412854-05mg | MyBiosource | 0.5mg | EUR 505 |
Human Doxorubicin-Stimulated HeLa Whole Cell Lysate |
|||
MBS8412854-5x05mg | MyBiosource | 5x0.5mg | EUR 2050 |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
IHUHELADTLN200UG | Innovative research | each | EUR 427 |
Description: Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
MBS8412853-02mg | MyBiosource | 0.2mg | EUR 605 |
Human Doxorubicin-Stimulated HeLa Nuclear Extract Lysate |
|||
MBS8412853-5x02mg | MyBiosource | 5x0.2mg | EUR 2550 |
Doxorubicin-hydrazone-caproyl-maleimide Hydrochloride (~80%) |
|||
D399610 | Toronto Research Chemicals | 250mg | EUR 150 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-100mg | MyBiosource | 100(mg | EUR 435 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-1g | MyBiosource | 1g | EUR 1045 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-250mg | MyBiosource | 250mg | EUR 615 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-500mg | MyBiosource | 500mg | EUR 825 |
Doxorubicin, Hydrochloride (Adriacin, Adriblastina, Adriamycin, Caelyx) |
|||
MBS6117812-5x1g | MyBiosource | 5x1g | EUR 4560 |
N-Trifluoroacetyl-4'-nitobenzoate-8-(2-acetyloxy) Doxorubicin |
|||
MBS651570-025mg | MyBiosource | 0.25mg | EUR 575 |
N-Trifluoroacetyl-4'-nitobenzoate-8-(2-acetyloxy) Doxorubicin |
|||
MBS651570-5x025mg | MyBiosource | 5x0.25mg | EUR 2440 |
7,8-Desacetyl-9,10-dehydro Daunorubicinone (~90%)(Doxorubicin Impurity) |
|||
D288680 | Toronto Research Chemicals | 10mg | EUR 4281 |
Description: 1159977-24-8 |
N-(9-Fluorenylmethoxycarbonyl)-4',6,8,11-tetra-O-benzoyl Doxorubicin |
|||
MBS651513-10mg | MyBiosource | 10mg | EUR 610 |
N-(9-Fluorenylmethoxycarbonyl)-4',6,8,11-tetra-O-benzoyl Doxorubicin |
|||
MBS651513-5x10mg | MyBiosource | 5x10mg | EUR 2600 |
N-Trifluoroacetyl-8-(2-tert-butyl(dimethyl)silyl]oxy) Doxorubicin |
|||
MBS651340-5mg | MyBiosource | 5mg | EUR 575 |
N-Trifluoroacetyl-8-(2-tert-butyl(dimethyl)silyl]oxy) Doxorubicin |
|||
MBS651340-5x5mg | MyBiosource | 5x5mg | EUR 2440 |
Bojanus grew to become a professor of zoology in 1806 and a professor of comparative anatomy in 1814 at Vilnius College, the place, amongst different accomplishments, he established himself as a founder of recent veterinary medication and a pioneer of pre-Darwinian and pre-Lamarckian evolutionism.